» Articles » PMID: 25192722

The Functional Proteomics Analysis of VEGF-treated Human Epithelial Ovarian Cancer Cells

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Sep 7
PMID 25192722
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular endothelial growth factor (VEGF), one of the most important angiogenic factor, can impact the tumor cell proliferation and invasion, but the mechanism remains unclear. This study is to investigate the key proteins which may play an important role in the VEGF-induced progress of ovarian cancer cells. The total protein from HO-8910 cells was separated by two-dimensional electrophoresis (2-DE), and differentially expressed proteins were identified by matrix-assisted laser desorption and ionization time-of-flight tandem mass spectrometry (MALDI-TOF MS) and PDQuest image analysis software. Furthermore, real-time PCR, Western blot, and immunocytochemistry were also used to confirm different expression levels of differential proteins. Morphological changes and invasion capability were evaluated by electron microscope and Matrigel invasion assay, respectively. The highly reproducible and well-resolved 2-DE patterns of both HO-8910/VEGF and HO-8910 cells were acquired. A total of 17 expressed differential proteins were identified, 8 proteins were upregulated (ACTB, TIM, PDIA3, PDIA1, DCTN2, KIC17, SIAS, and KIC10) and 9 downregulated (KIC18, GRP78, CAPG, PPIA, ROA2, LMNA, EZRI, ADRM1, and ENOA). Ultrastructure of VEGF-treated group showed more malignant characteristic compared with control group, an obvious increase in the number of cells penetrating the Matrigel membrane in VEGF-treated group (P < 0.05). These results suggested that VEGF could impact ovarian cancer's malignant progression by regulating expression of associated proteins.

Citing Articles

Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis.

Ye M, Lin Y, Pan S, Wang Z, Zhu X Front Oncol. 2021; 11:745808.

PMID: 34631583 PMC: 8497990. DOI: 10.3389/fonc.2021.745808.


, a Novel Hypoxia Target Gene Related to Gastric Cancer Invasion and Metastasis.

Zhang J, Guo S, Wu Y, Zheng Z, Wang Y, Zhao Y Biomed Res Int. 2019; 2019:9749751.

PMID: 31467922 PMC: 6699373. DOI: 10.1155/2019/9749751.


Function of the macrophage-capping protein in colorectal carcinoma.

Wu W, Chen J, Ding Q, Yang S, Wang J, Yu H Oncol Lett. 2017; 14(5):5549-5555.

PMID: 29113183 PMC: 5656019. DOI: 10.3892/ol.2017.6888.

References
1.
Yang Y, Xiao Z, Chen Z, Zhang G, Yi H, Zhang P . Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics. 2006; 6(6):2009-21. DOI: 10.1002/pmic.200402031. View

2.
Kobel M, Gradhand E, Zeng K, Schmitt W, Kriese K, Lantzsch T . Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol. 2006; 25(2):121-30. DOI: 10.1097/01.pgp.0000185410.39050.ac. View

3.
Ji Y, Wang Q, Li Y, Wang Z . Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis. Tumour Biol. 2013; 35(3):2787-93. DOI: 10.1007/s13277-013-1371-1. View

4.
Decio A, Taraboletti G, Patton V, Alzani R, Perego P, Fruscio R . Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms. Am J Pathol. 2014; 184(4):1050-1061. DOI: 10.1016/j.ajpath.2013.12.030. View

5.
Thongwatchara P, Promwikorn W, Srisomsap C, Chokchaichamnankit D, Boonyaphiphat P, Thongsuksai P . Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol Rep. 2011; 26(1):185-91. DOI: 10.3892/or.2011.1266. View